Reentry Incentives for Opioid Use Disorder
(RISE-CM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program designed to help individuals continue medication for opioid use disorder (MOUD) after leaving jail. The program, called the Reentry Incentives and Support for Engagement with Contingency Management (RISE-CM) Intervention, uses rewards, such as gift cards, to encourage attendance at MOUD appointments and counseling. Researchers aim to determine if this reward system can reduce the risk of overdose and improve health after release. Individuals currently in jail, taking MOUD, and planning to continue treatment after release may be well-suited for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative approaches that could significantly enhance post-release health outcomes.
Will I have to stop taking my current medications?
The trial does not require you to stop taking your current medications. In fact, it encourages you to continue your medication for opioid use disorder (MOUD) after release from jail.
What prior data suggests that this program is safe for participants?
Studies have shown that contingency management (CM), the program tested in this study, is generally safe and well-tolerated. CM offers rewards to encourage positive behaviors, such as attending treatment sessions. Research indicates that CM does not have significant negative effects because it uses safe incentives like gift cards or small rewards.
No specific data on negative events for CM exists because it doesn't involve medication or invasive procedures. Instead, it functions as a supportive program to help individuals adhere to their treatment plans. Various settings have studied CM's safety, and it is considered a low-risk approach.
Overall, CM is seen as a promising way to help individuals continue their medication for opioid use disorder (MOUD) after release from jail. Thorough research has demonstrated its effectiveness, and existing evidence supports its safety.12345Why are researchers excited about this trial?
Researchers are excited about the RISE-CM Intervention for opioid use disorder because it incorporates contingency management, a method that offers tangible incentives to encourage positive behavior changes. Unlike traditional treatments like methadone or buprenorphine, which focus on reducing withdrawal symptoms and cravings, RISE-CM actively engages participants by rewarding their progress, potentially increasing motivation and long-term success. This approach aims to support individuals in their recovery journey by fostering engagement and retention, addressing key challenges in current treatment methods.
What evidence suggests that the RISE-CM intervention is effective for supporting treatment engagement after release from jail?
Research has shown that contingency management (CM), a program offering rewards for positive actions, can help people adhere to medication for opioid use disorder (MOUD). Studies have found that CM increases the likelihood of continued treatment and improves health outcomes. A review also found that CM reduces behavior problems in those on MOUD. Additionally, using CM with technology, such as smartphone apps, has been linked to better treatment results. These findings suggest that CM can be a useful tool for individuals transitioning from jail back into the community, helping to lower their risk of overdose. In this trial, all participants will enroll in the RISE-CM Intervention, which incorporates these principles to support reentry and engagement with treatment.12678
Who Is on the Research Team?
Linda Peng, MD
Principal Investigator
Oregon Health and Science University
Are You a Good Fit for This Trial?
This trial is for English-speaking adults over 18 who are currently in Clatsop County Jail, enrolled in the jail's medication program for opioid use disorder (MOUD), and plan to continue MOUD after release with Clatsop Behavioral Healthcare.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Incarceration Phase
Participants complete one visit while incarcerated, receiving a small incentive for enrolling in the CM program
Post-Release Treatment
Participants earn gift cards for attending MOUD appointments and counseling sessions after release
Follow-up
Participants are monitored for treatment engagement and completion of surveys at baseline and 3 months
What Are the Treatments Tested in This Trial?
Interventions
- Reentry Incentives and Support for Engagement with Contingency Management (RISE-CM) Intervention
Trial Overview
The study tests a contingency management program offering incentives like commissary credit or gift cards to encourage people on MOUD to attend their appointments and counseling sessions after leaving jail, aiming to reduce overdose risk.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
All participants are enrolled in the intervention arm.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oregon Health and Science University
Lead Sponsor
Clatsop Behavioral Healthcare
Collaborator
Oregon Health Authority
Collaborator
Clatsop County Corrections
Collaborator
Citations
Reentry Incentives and Support for Engagement With ...
Participant reported addiction severity using the validated Brief Addiction Monitor, a 17-item, multidimensional progress monitoring tool ...
2.
trial.medpath.com
trial.medpath.com/clinical-trial/0b64b7d73d928c22/nct07322588-medication-opioid-use-disorder-contingency-managementReentry Incentives and Support for Engagement ... - MedPath
This study is testing whether a program that offers rewards, called contingency management (CM), can help people stay on MOUD after they return ...
3.
ctv.veeva.com
ctv.veeva.com/study/reentry-incentives-and-support-for-engagement-with-contingency-managementReentry Incentives and Support for Engagement With ...
This study is testing whether a program that offers rewards, called contingency management (CM), can help people stay on MOUD after they return ...
Contingency Management for Patients Receiving Medication ...
This systematic review and meta-analysis examines the efficacy of contingency management for treating comorbid behavioral problems in individuals receiving ...
Smartphone App–Based Contingency Management and ...
These findings suggest that adding app-based contingency management to MOUD is associated with better treatment outcomes in clinical settings.
Reentry Incentives for Opioid Use Disorder (RISE-CM Trial)
This study is testing whether a program that offers rewards, called contingency management (CM), can help people stay on MOUD after they return ...
Rewarding recovery: the time is now for contingency ...
This paper provides a succinct, up-to-date overview of the current evidence base for contingency management for opioid use disorder.
Contingency Management Myths vs. Facts
Perhaps most importantly, a 2021 meta-analysis on long-term outcomes showed participants receiving contingency management were 22% more likely ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.